Learning Objectives:
1. Understand the methodologic considerations underlying trial emulation using observational data.
2. Compare glucose-lowering drugs with respect to achieving and maintaining glycemic control (emulation of the GRADE trial).
3. Compare glucose-lowering drugs with respect to reducing cardiovascular events in patients at moderate cardiovascular risk.
Session date:
02/26/2024 - 5:00pm to 6:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Rozalina G. McCoy, M.D., M.S.